Pro •Duct Breast Aspirator & Catheter

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 8
Volume 9
Issue 8

MENLO PARK, Calif–Pro •Duct Health, Inc. has launched the Pro •Duct Breast Aspirator and Catheter for use in ductal lavage.

MENLO PARK, Calif–Pro•Duct Health, Inc. has launched the Pro•Duct Breast Aspirator and Catheter for use in ductal lavage.

Preliminary data of a trial of ductal lavage in 515 high-risk women showed atypical breast epithelial cells in 15% of women and high-grade atypia in 4%. In two cases of malignant and markedly atypical cells, both women had excisional biopsies confirming ductal carcinoma in situ (DCIS), even though mammograms were normal before and after ductal lavage (36th ASCO, New Orleans, abstract 295).

The breast aspirator applies mild suction to draw fluid from the nipple and is used to identify which milk ducts to lavage. Previous research has shown that nipple aspirate fluid production upon nipple aspiration is associated with roughly a doubling in breast cancer risk, the company said in a news release.

To perform the ductal lavage procedure, a flexible microcatheter is inserted approximately half an inch into the milk ducts through the natural nipple opening. A small amount of saline solution is introduced, washing cells out of the lining of the milk ducts.

Recent Videos
Patients with cancer are subjected to fewer radiotherapy-induced toxicities because of newer, more advanced technologies.
Hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discuss presentations at ESMO 2025 that may impact bladder, kidney, and prostate cancer care.
Mandating additional immunotherapy infusions may help replenish T cells and enhance tumor penetration for solid tumors, including GI malignancies.
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
Receiving information regarding tumor-associated antigens or mutational statuses from biopsies may help treatment selection in GI malignancies.
An easy-to-access database allows one to see a patient’s cancer stage, prior treatment, and survival outcomes in a single place.
Related Content